The pharmaceutical industry is under siege. They are being threatened by a flood of counterfeit pharmaceuticals that are selling at an estimated rate of $205 billion a year worldwide. The cost of this black market cannot just be counted in dollars and cents. It is estimated that 2,000 people per day are dying as a result of taking counterfeit drugs. Many countries have already taken steps to stem the tide of these drugs.
In the US, California has already passed legislation that will require every prescription drug sold in the state to have a ‘pedigree’. The law has set firm deadlines for compliance that begins in 2015 and requires total compliance by all in 2017.
The US FDA is not far behind California. The FDA is currently working on legislation that will over-rule the California law (and any other state laws) regarding pedigree requirements. The basis for the FDA system will require a Track and Trace system in place at the point of manufacture.
Are you ready for serialization? For more information on this topic, New England Machinery, Inc. offers a free white paper entitled “The Why, What and How of Track and Trace”. Visit www.neminc.com to download a copy.
The author, Marge Bonura, is the Director of Sales & Marketing for New England Machinery, Inc. (NEM). NEM is a leading manufacturer of bottle unscramblers, cappers, orienters, retorquers, lidders, pluggers, pump sorter/placers, scoop feeders, hopper elevators and much more. The company has been in business since 1974 selling to the food, beverage, pharmaceutical, personal care, chemical, household products, automotive and other industries. For more information on NEM, visit their website at www.neminc.com.
Wednesday, May 16, 2012
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment